TRI – Thrombosis Research Institute – Innovators in Thrombosis

Patron

HRH The Prince Philip
Duke of Edinburgh KG KT

Court of Patrons

The Most Hon The Marquess
of Salisbury KCVO PC DL (Chairman)
Sir Michael Edwardes
Mr David McDonough OBE
Mr Björn Saven
Sir Julian Seymour CBE
The Lord Sherbourne of Didsbury CBE
Sir Mark Worthington OBE

Founder

Professor V.V. Kakkar
OBE FRCS FRCSE Hon DSc

Trustees

Mr Patrick Burgess MBE OBE DL (Chairman)
Dr Jeffrey Herbert
Miss Joanna Kaye
Sir Martin Sorrell
Mr Guy Weston

Director

Rt Hon Professor The Lord Kakkar PC

Deputy Director/Chief Operating Officer

Ms Gloria Kayani

Latest Tweets

Retweet on Twitter Thrombosis Research Institute Retweeted

The British Journal of Cardiology @BrJCardiol·

22h 1184032189840875526

Paediatric and adult populations show significant differences in absorption, distribution, metabolism and excretion of various drugs. Understanding the differences with respect to adulthood
is fundamental for effectiveness & limiting toxic drug effects. DOI: 10.7573/dic.212608

Reply on Twitter 1184032189840875526 Retweet on Twitter 11840321898408755261 Like on Twitter 1184032189840875526 Twitter 1184032189840875526

Retweet on Twitter Thrombosis Research Institute Retweeted

GARFIELD Registry @GARFIELD_reg·

21h 1184045594349899776

Rivaroxaban compared with Warfarin in morbidly obese patients with VTE: #VTE #thrombosis #cardiovascular #Insight @EndoAdvisor

Rivaroxaban Compared With Warfarin in Morbidly Obese Patients With Venous Thromboembolism - Endocrinology Advisor

Results from a new real-world study evaluating rivaroxaban (Xarelto; Janssen), a factor Xa inhibitor, in morbidly obese patients were recently publish...

www.endocrinologyadvisor.com

Reply on Twitter 1184045594349899776 Retweet on Twitter 11840455943498997764 Like on Twitter 11840455943498997763 Twitter 1184045594349899776

Thrombosis Research Institute @TRI_Thrombosis·

14 Oct 1183665083043471361

Our #MondayMotivation...this month marks 30 years at Manresa Road for TRI. PM Margaret Thatcher and Prince Philip opened the building in October 1989. CVD research marches on, as vital today as it was when we started out, evident in the support behind @thrombosisday yesterday

Reply on Twitter 1183665083043471361 Retweet on Twitter 11836650830434713612 Like on Twitter 11836650830434713615 Twitter 1183665083043471361

Thrombosis Research Institute @TRI_Thrombosis·

10 Oct 1182265130836471809

The development of standards allowing a common language and approach to thrombosis management all over the world is so essential – it’s a great honour to support the #WorldThrombosisDay movement!
Learn more at https://t.co/kzcw8yNA8Y #WTDay19
#KeepLifeFlowing

Reply on Twitter 1182265130836471809 Retweet on Twitter 11822651308364718091 Like on Twitter 11822651308364718091 Twitter 1182265130836471809

Thrombosis Research Institute @TRI_Thrombosis·

9 Oct 1181867973503590400

Delighted to join @ThrombosisDay for its annual Twitter Chat #ClotChat, discussing the importance of #thrombosis #awareness #prevention for #WTDay19

Reply on Twitter 1181867973503590400 Retweet on Twitter 11818679735035904007 Like on Twitter 11818679735035904008 Twitter 1181867973503590400

QUICK LINKS

Thrombosis News

More news >

World Thrombosis Day – 5 Years On

Click to view the article
Article source: The Lancet

Scientists identify biomarkers to predict risk of...

Click to view the article
Article source: News Medical

Alcohol abstinence reduces arrhythmia recurrences, BP in...

Click to view the article
Article source: Healio (Cardiology Today)

Interfacility transfer may increase risk of venous...

Click to view the article
Article source: Healio

Introduction to TRI

View brochure

Click here to scroll down to the page content

TRI: Past, Present and Future

Hear more about how TRI started and what it does today.

Our Mission

At the Thrombosis Research Institute, we are committed to saving millions of lives, preventing long term disability and reducing healthcare costs by delivering pioneering advances in the detection, prevention and treatment of thrombosis.

Get the details

Our Achievements

Our multi-disciplinary programme of laboratory and clinical research has contributed to major advances in venous thromboembolism that have changed clinical practice, and enhanced knowledge and management of atrial fibrillation.

Get the details

Our Research

The Thrombosis Research Institute has been at the centre of global understanding of thrombosis for several decades, producing the highest calibre research into the condition.

Get the details

Innovators in thrombosis - worldwide!

Unveiled at our 2019 ambassadors meeting in Abu Dhabi, this infographic celebrates the scale and vital output from three of our global thrombosis registries.

View Now Back to site